CORD-19:3f9572ae671d876279b4d2cd6b6544b24fb3e52d / 24482-24794
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T140","span":{"begin":0,"end":312},"obj":"Sentence"},{"id":"TextSentencer_T140","span":{"begin":0,"end":312},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"135 The level of cystatin F mRNA was increased in the granulocytes of the patients with polycythemia vera, a myeloproliferative disorder characterized by an increased proliferation of cells of myeloid lineages 136 and downregulated in peripheral blood mononuclear cells of patients with chronic fatigue syndrome."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T39","span":{"begin":88,"end":100},"obj":"Phenotype"},{"id":"T40","span":{"begin":109,"end":136},"obj":"Phenotype"},{"id":"T41","span":{"begin":287,"end":302},"obj":"Phenotype"}],"attributes":[{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0001901"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0005547"},{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0012432"}],"text":"135 The level of cystatin F mRNA was increased in the granulocytes of the patients with polycythemia vera, a myeloproliferative disorder characterized by an increased proliferation of cells of myeloid lineages 136 and downregulated in peripheral blood mononuclear cells of patients with chronic fatigue syndrome."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T56","span":{"begin":246,"end":251},"obj":"Body_part"}],"attributes":[{"id":"A56","pred":"uberon_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"135 The level of cystatin F mRNA was increased in the granulocytes of the patients with polycythemia vera, a myeloproliferative disorder characterized by an increased proliferation of cells of myeloid lineages 136 and downregulated in peripheral blood mononuclear cells of patients with chronic fatigue syndrome."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T83","span":{"begin":88,"end":105},"obj":"Disease"},{"id":"T84","span":{"begin":88,"end":100},"obj":"Disease"},{"id":"T85","span":{"begin":109,"end":136},"obj":"Disease"},{"id":"T86","span":{"begin":287,"end":311},"obj":"Disease"},{"id":"T54650","span":{"begin":88,"end":105},"obj":"Disease"},{"id":"T5088","span":{"begin":88,"end":100},"obj":"Disease"},{"id":"T86893","span":{"begin":109,"end":136},"obj":"Disease"},{"id":"T56521","span":{"begin":287,"end":311},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0009891"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0005571"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0020076"},{"id":"A86","pred":"mondo_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/MONDO_0005404"},{"id":"A51375","pred":"mondo_id","subj":"T54650","obj":"http://purl.obolibrary.org/obo/MONDO_0009891"},{"id":"A84712","pred":"mondo_id","subj":"T5088","obj":"http://purl.obolibrary.org/obo/MONDO_0005571"},{"id":"A76480","pred":"mondo_id","subj":"T86893","obj":"http://purl.obolibrary.org/obo/MONDO_0020076"},{"id":"A59536","pred":"mondo_id","subj":"T56521","obj":"http://purl.obolibrary.org/obo/MONDO_0005404"}],"text":"135 The level of cystatin F mRNA was increased in the granulocytes of the patients with polycythemia vera, a myeloproliferative disorder characterized by an increased proliferation of cells of myeloid lineages 136 and downregulated in peripheral blood mononuclear cells of patients with chronic fatigue syndrome."}